Elon Musk Is Wrong About Nebius: Rating Upgrade (NASDAQ:NBIS)
Elon Musk Is Wrong About Nebius: Rating Upgrade (NASDAQ:NBIS) Seeking Alpha
Covered in this story
Analyst targets on Nebius Group
- Rosenblatt Securities: $221 → $304 by Oct 2027 · Buy via TIKR.com
- BNP Paribas Exane: $243 → $399 by Sep 2027 · Outperform via finance.yahoo.com
- Baird: $278 → $340 by Aug 2027 via Yahoo Finance Singapore
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $NBIS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nebius Group →Dalsna Finance is currently tracking 49 stories mentioning Nebius Group, the earliest published 5 May 2026.
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.